TY - JOUR
T1 - Regulation of cytotoxic T lymphocyte triggering by PIR-B on dendritic cells
AU - Endo, Shota
AU - Sakamoto, Yuzuru
AU - Kobayashi, Eiji
AU - Nakamura, Akira
AU - Takai, Toshiyuki
PY - 2008/9/23
Y1 - 2008/9/23
N2 - Priming of cytotoxic T lymphocytes (CTLs) by dendritic cells (DCs) is crucial for elimination of pathogens and malignant cells. To activate CTLs, DCs present antigenic peptide-complexed MHC class I molecules (MHC-I) that will be recognized by the CTLs with T cell receptors and CD8 molecules. Here we show that paired Ig-like receptor (PIR)-B, an MHC-I receptor expressed on antigen-presenting cells, can regulate CTL triggering by blocking the access of CD8 molecules to MHC-I. PIR-B-deficient DCs evoked CTLs more efficiently, leading to accelerated graft and tumor rejection. PIR-B+ non-DC transfectant cells served as less efficient stimulators and targets for CTLs than PIR-B- cells at the effector phase in vitro. On surface plasmon resonance analysis, PIR-B and CD8αα were revealed to compete in binding to MHC-I. Our results may provide a novel strategy for regulating CTL-mediated immunity and diseases in a sterical manner.
AB - Priming of cytotoxic T lymphocytes (CTLs) by dendritic cells (DCs) is crucial for elimination of pathogens and malignant cells. To activate CTLs, DCs present antigenic peptide-complexed MHC class I molecules (MHC-I) that will be recognized by the CTLs with T cell receptors and CD8 molecules. Here we show that paired Ig-like receptor (PIR)-B, an MHC-I receptor expressed on antigen-presenting cells, can regulate CTL triggering by blocking the access of CD8 molecules to MHC-I. PIR-B-deficient DCs evoked CTLs more efficiently, leading to accelerated graft and tumor rejection. PIR-B+ non-DC transfectant cells served as less efficient stimulators and targets for CTLs than PIR-B- cells at the effector phase in vitro. On surface plasmon resonance analysis, PIR-B and CD8αα were revealed to compete in binding to MHC-I. Our results may provide a novel strategy for regulating CTL-mediated immunity and diseases in a sterical manner.
KW - CTL priming
KW - MHC class I
KW - Regulatory receptor
UR - http://www.scopus.com/inward/record.url?scp=55749105398&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=55749105398&partnerID=8YFLogxK
U2 - 10.1073/pnas.0804571105
DO - 10.1073/pnas.0804571105
M3 - Article
C2 - 18787130
AN - SCOPUS:55749105398
SN - 0027-8424
VL - 105
SP - 14515
EP - 14520
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 38
ER -